These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24068014)

  • 1. High-throughput matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative approach to monitoring drug resistance of hepatitis B virus.
    Rybicka M; Stalke P; Dreczewski M; Smiatacz T; Bielawski KP
    J Clin Microbiol; 2014 Jan; 52(1):9-14. PubMed ID: 24068014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An initial assessment of correlations between host- and virus-related factors affecting analogues antiviral therapy in HBV chronically infected patients.
    Stalke P; Rybicka M; Wróblewska A; Dreczewski M; Stracewska E; Smiatacz T; Bielawski KP
    Med Sci Monit; 2014 Feb; 20():321-8. PubMed ID: 24569300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments.
    Hong SP; Kim NK; Hwang SG; Chung HJ; Kim S; Han JH; Kim HT; Rim KS; Kang MS; Yoo W; Kim SO
    J Hepatol; 2004 May; 40(5):837-44. PubMed ID: 15094233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry.
    Luan J; Yuan J; Li X; Jin S; Yu L; Liao M; Zhang H; Xu C; He Q; Wen B; Zhong X; Chen X; Chan HL; Sung JJ; Zhou B; Ding C
    Clin Chem; 2009 Aug; 55(8):1503-9. PubMed ID: 19541863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison study of HBV-P mutation detection by MALDI-TOF Ms and direct PCR sequencing].
    Liu F; Xiao T; Wang L; Xie JP; Li GH; Liang QL; Luo CH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):436-9. PubMed ID: 22053374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy.
    Ding C; Wong VW; Chow KC; Chan HY; Hui AY; Wong GL; Lo YM; Sung JJ; Chan HL
    Antivir Ther; 2006; 11(8):1041-9. PubMed ID: 17302374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS.
    Rybicka M; Stalke P; Bielawski KP
    Clin Microbiol Infect; 2015 Mar; 21(3):288.e1-4. PubMed ID: 25658547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough.
    Lee CH; Kim SO; Byun KS; Moon MS; Kim EO; Yeon JE; Yoo W; Hong SP
    Gastroenterology; 2006 Apr; 130(4):1144-52. PubMed ID: 16618409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.
    Kim HS; Han KH; Ahn SH; Kim EO; Chang HY; Moon MS; Chung HJ; Yoo W; Kim SO; Hong SP
    Antivir Ther; 2005; 10(3):441-9. PubMed ID: 15918335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy.
    Yeh ML; Huang CF; Huang CI; Liu SF; Yang HL; Hsieh MY; Huang JF; Dai CY; Chuang WL; Yu ML
    PLoS One; 2014; 9(7):e101790. PubMed ID: 25000502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
    Woo HY; Park H; Kim BI; Jeon WK; Cho YK; Kim YJ
    Antivir Ther; 2007; 12(1):7-13. PubMed ID: 17503742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain.
    León P; Pozo F; Echevarría JM
    Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):133-7. PubMed ID: 14987532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
    Lok AS; Zoulim F; Locarnini S; Mangia A; Niro G; Decraemer H; Maertens G; Hulstaert F; De Vreese K; Sablon E
    J Clin Microbiol; 2002 Oct; 40(10):3729-34. PubMed ID: 12354872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients.
    Mello FC; Lago BV; Lewis-Ximenez LL; Fernandes CA; Gomes SA
    BMC Microbiol; 2012 Jun; 12():96. PubMed ID: 22672436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High throughput detection of drug-resistance gene mutations in HBV using MALDI-TOF mass spectrometry].
    Zhou BP; Zhang HM; Li XH; Yuan J; Li W; Xu LM; Wang HS; Chen XC; Ding CM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):351-3. PubMed ID: 19469172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.
    Lok AS; Ganova-Raeva L; Cloonan Y; Punkova L; Lin HS; Lee WM; Ghany MG;
    J Viral Hepat; 2017 Nov; 24(11):1032-1042. PubMed ID: 28581155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients.
    Kwon SY; Park YK; Ahn SH; Cho ES; Choe WH; Lee CH; Kim BK; Ko SY; Choi HS; Park ES; Shin GC; Kim KH
    J Virol; 2010 May; 84(9):4494-503. PubMed ID: 20164224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.
    Gomes-Gouvêa MS; Ferreira AC; Teixeira R; Andrade JR; Ferreira AS; Barros LM; Rezende RE; Nastri AC; Leite AG; Piccoli LZ; Galvan J; Conde SR; Soares MC; Kliemann DA; Bertolini DA; Kunyoshi AS; Lyra AC; Oikawa MK; de Araújo LV; Carrilho FJ; Mendes-Corrêa MC; Pinho JR
    Antivir Ther; 2015; 20(4):387-95. PubMed ID: 25624410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach.
    Bhattacharya D; Lewis MJ; Lassmann B; Phan T; Knecht G; Bickel M; Yang OO
    J Virol Methods; 2013 Jun; 190(1-2):34-40. PubMed ID: 23454647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technique for the early detection of drug-resistant HBV DNA during antiviral therapy.
    Yeon JE
    Intervirology; 2008; 51 Suppl 1():7-10. PubMed ID: 18544942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.